Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Lovenox/Clexane receives approvals in 11 additional countries

Jan. 20, 1998

No Comments

DuPont Merck develops new factor Xa inhibitors as anticoagulants

Jan. 16, 1998

No Comments

Oral heparin preparation completes additional phase I trials

Jan. 16, 1998

No Comments

Merck & Co. describes new thrombin inhibitors

Jan. 14, 1998

No Comments

Audit of Genzyme Transgenics' rhATIII production facility triggers milestone

Jan. 13, 1998

No Comments

Roberts seeks to broaden market for Agrylin

Jan. 13, 1998

No Comments

Cell adhesion inhibitors from Merck KGaA

Jan. 12, 1998

No Comments

Thrombin inhibitors reported by BMS

Jan. 9, 1998

No Comments

Vasoflux preclinical data presented at major hematology congress

Jan. 8, 1998

No Comments

Efficacy of recombinant hirudin demonstrated in patients with DIC

Jan. 8, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Hematologic
RSS

Lovenox/Clexane receives approvals in 11 additional countries

DuPont Merck develops new factor Xa inhibitors as anticoagulants

Oral heparin preparation completes additional phase I trials

Merck & Co. describes new thrombin inhibitors

Audit of Genzyme Transgenics' rhATIII production facility triggers milestone

Roberts seeks to broaden market for Agrylin

Cell adhesion inhibitors from Merck KGaA

Thrombin inhibitors reported by BMS

Vasoflux preclinical data presented at major hematology congress

Efficacy of recombinant hirudin demonstrated in patients with DIC

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Phase III AMD miss leaves BLA Outlook same with bevacizumab

Hematologic RSS

Hematologic
RSS